tiprankstipranks
Advertisement
Advertisement

RNAZ Stock Latest News

TransCode Highlights Progress of Lead RNA Cancer Therapeutic
Company AnnouncementsTransCode Highlights Progress of Lead RNA Cancer Therapeutic
12d ago
8K
RNAZ
Transcode reports results from Phase 1a dose escalation trial with TTX-MC138
PremiumThe Fly
Transcode reports results from Phase 1a dose escalation trial with TTX-MC138
27d ago
RNAZ
TransCode Therapeutics Advances TTX-MC138 After Positive Phase 1a
PremiumCompany Announcements
TransCode Therapeutics Advances TTX-MC138 After Positive Phase 1a
27d ago
8K
RNAZ
TransCode Sets Key Deadlines for 2026 Shareholder Meeting
PremiumCompany Announcements
TransCode Sets Key Deadlines for 2026 Shareholder Meeting
29d ago
8K
RNAZ
Transcode Therapeutics initiates Phase 2a clinical trial with TTX-MC138
PremiumThe Fly
Transcode Therapeutics initiates Phase 2a clinical trial with TTX-MC138
1M ago
RNAZ
TransCode Therapeutics Receives Nasdaq Listing Deficiency Notice
PremiumCompany AnnouncementsTransCode Therapeutics Receives Nasdaq Listing Deficiency Notice
1M ago
8K
RNAZ
Transcode Therapeutics files to sell 1.53M shares of common stock for holders
Premium
The Fly
Transcode Therapeutics files to sell 1.53M shares of common stock for holders
2M ago
RNAZ
Transcode Therapeutics files to sell 15.96M shares of common stock for holders
Premium
The Fly
Transcode Therapeutics files to sell 15.96M shares of common stock for holders
2M ago
RNAZ
Transcode Therapeutics appoints Anna Moore as Chair of Scientific Advisory
PremiumThe Fly
Transcode Therapeutics appoints Anna Moore as Chair of Scientific Advisory
2M ago
RNAZ
Transcode Therapeutics signs research agreement with Michigan State University
PremiumThe Fly
Transcode Therapeutics signs research agreement with Michigan State University
2M ago
RNAZ
Transcode Therapeutics signs flexible financing agreement for up to $20M
PremiumThe Fly
Transcode Therapeutics signs flexible financing agreement for up to $20M
3M ago
RNAZ
TransCode Therapeutics Secures New Financing to Extend Runway
PremiumCompany Announcements
TransCode Therapeutics Secures New Financing to Extend Runway
3M ago
8K
RNAZ
TransCode Therapeutics Delays 2025 Annual Filing
PremiumCompany AnnouncementsTransCode Therapeutics Delays 2025 Annual Filing
3M ago
RNAZ
TransCode Therapeutics Expands Pipeline With Oncolytic Virus Deal
Premium
Company Announcements
TransCode Therapeutics Expands Pipeline With Oncolytic Virus Deal
4M ago
8K
RNAZ
Transcode Therapeutics enters exclusive license agreement with Unleash
Premium
The Fly
Transcode Therapeutics enters exclusive license agreement with Unleash
4M ago
RNAZ
TransCode Unveils Tumor-Selective RIG-I Agonist Imaging Strategy
PremiumCompany Announcements
TransCode Unveils Tumor-Selective RIG-I Agonist Imaging Strategy
4M ago
8K
RNAZ
TransCode Therapeutics Advances Phase 2a Colorectal Cancer Trial
PremiumCompany Announcements
TransCode Therapeutics Advances Phase 2a Colorectal Cancer Trial
5M ago
8K
RNAZ
Transcode Therapeutics, Quantum Leap submit IND for Phase 2a trial of TTX-MC138
PremiumThe Fly
Transcode Therapeutics, Quantum Leap submit IND for Phase 2a trial of TTX-MC138
5M ago
RNAZ
TransCode Therapeutics reports promising preclinical glioblastoma results
PremiumCompany Announcements
TransCode Therapeutics reports promising preclinical glioblastoma results
6M ago
8K
RNAZ
Transcode Therapeutics announces publication of data supporting TTX-MC138
PremiumThe FlyTranscode Therapeutics announces publication of data supporting TTX-MC138
6M ago
RNAZ
TransCode Therapeutics Strengthens Board with Veteran Financial Expert
Premium
Company Announcements
TransCode Therapeutics Strengthens Board with Veteran Financial Expert
6M ago
8K
RNAZ
TransCode Announces Collaboration for Phase 2a Trial
Premium
Company Announcements
TransCode Announces Collaboration for Phase 2a Trial
7M ago
8K
RNAZ

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >